WAI CHUN BIOTEC (00660) announced its interim results for the six months ended December 31, 2025. The company recorded revenue of HK$352 million, representing an increase of 118.65% compared to the same period last year. The loss attributable to company owners was HK$5.939 million, a decrease of 56.53% year-on-year. The loss per share was HK3.33 cents. The increase in revenue was attributed to heightened market consumption and demand during the period. For the six months ended December 31, 2025, the Group achieved a gross profit and gross profit margin of approximately HK$35.7 million and 10.1%, respectively. This compares to a gross profit of approximately HK$21.1 million and a gross profit margin of about 13.1% for the six months ended December 31, 2024. This represents an increase in gross profit of approximately HK$14.5 million, while the gross profit margin decreased by 3.0 percentage points.